Switch to:
GuruFocus has detected 4 Warning Signs with Pfizer Inc $PFE.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Pfizer Inc (NYSE:PFE)
Accounts Payable & Accrued Expense
$6,041 Mil (As of Mar. 2017)

Pfizer Inc's quarterly accounts payable & accrued expense increased from Sep. 2016 ($8,503 Mil) to Dec. 2016 ($9,404 Mil) but then declined from Dec. 2016 ($9,404 Mil) to Mar. 2017 ($6,041 Mil).

Pfizer Inc's annual accounts payable & accrued expense increased from Dec. 2014 ($7,466 Mil) to Dec. 2015 ($8,249 Mil) and increased from Dec. 2015 ($8,249 Mil) to Dec. 2016 ($9,404 Mil).


Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Pfizer Inc Annual Data

Accounts Payable & Accrued Expense 4,2443,41818,1738,6818,8149,0547,3677,4668,2499,404

Pfizer Inc Quarterly Data

Accounts Payable & Accrued Expense 7,4665,3477,3598,3558,2495,7707,3228,5039,4046,041
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat